Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Angewandte Chemie (International Ed. in English)|March 5, 2014
Selective inhibition of mutant Ras protein through covalent bindingJoachim Rudolph, David StokoeBioorganic & Medicinal Chemistry Letters|August 21, 2012
Ras inhibition via direct Ras binding--is there a path forward?Weiru Wang, Guowei Fang, Joachim RudolphCancer Discovery|April 3, 2021
Emerging Trends in Cancer Drug Discovery-From Drugging the "Undruggable" to Overcoming ResistanceJoachim Rudolph, Jeff Settleman, Shiva MalekNature Reviews. Drug Discovery|July 19, 2014
Phenotypic screening in cancer drug discovery - past, present and futureJohn G Moffat, Joachim Rudolph, David BaileyBioorganic & Medicinal Chemistry Letters|March 16, 2013
HCV versus HIV drug discovery: Déjà vu all over again?William J Watkins, Manoj C DesaiExpert Opinion on Therapeutic Patents|March 13, 2012
p21-Activated kinase inhibitors: a patent reviewJames J Crawford, Klaus P Hoeflich, Joachim RudolphNature Reviews. Drug Discovery|April 28, 2026
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategiesJoachim Rudolph, Klaus P Hoeflich, Arvin C DarThe Enzymes|July 19, 2014
p21-activated kinase inhibitorsJoachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.Journal of Medicinal Chemistry|November 22, 2014
Inhibitors of p21-activated kinases (PAKs)Joachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.Current Opinion in Drug Discovery & Development|July 3, 2010
HCV NS5B polymerase inhibitorsWilliam J Watkins, Adrian S Ray, Lee S ChongPageof 10